A new annual injection designed to prevent HIV has successfully completed a significant early safety trial.
Named lenacapavir, this long-acting medication inhibits the virus's ability to replicate. In…
Tag: HIVResearch
Named lenacapavir, this long-acting medication inhibits the virus's ability to replicate. In…